Screening for Mupirocin Resistance in Staphylococcus

Avr Jeya Sanju1, Sridharan Sathyamoorthy Kopula2, Kennedy Kumar Palraj2

  • 1Student, Department of Microbiology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra University , Porur, Chennai, India .

Abstract

Insights

Mupirocin resistance screening is crucial for Staphylococcus aureus and Coagulase-negative Staphylococcus (CoNS) infections. Disc diffusion may miss low-level mupirocin resistance, necessitating further testing for effective treatment.

Area of Science:

  • Clinical Microbiology
  • Antimicrobial Resistance
  • Dermatology

Background:

  • Mupirocin is a key topical antibiotic for Staphylococcus and Streptococcus infections.
  • Nasal mupirocin aids in eradicating methicillin-resistant Staphylococcus aureus (MRSA).
  • Increasing mupirocin usage has led to resistance and treatment failures.

Purpose of the Study:

  • To evaluate mupirocin resistance in Staphylococcus isolates.
  • To compare disc diffusion and minimum inhibitory concentration (MIC) methods for resistance detection.

Main Methods:

  • A cross-sectional study involving 100 Staphylococcus strains from skin infections.
  • Disc diffusion and agar dilution methods were used to determine mupirocin resistance.
  • Methicillin susceptibility was assessed using oxacillin and cefoxitin discs.

Main Results:

  • Mupirocin resistance detected in 12.5% of Staphylococcus aureus and 41% of CoNS by disc diffusion.
  • MIC testing revealed higher resistance rates: 19.6% for S. aureus and 43.1% for CoNS.
  • Coagulase-negative staphylococci (CoNS) exhibited higher mupirocin resistance than Staphylococcus aureus.

Conclusions:

  • Disc diffusion is a valuable initial screening tool for mupirocin resistance.
  • Mupirocin resistance is more prevalent in CoNS than S. aureus.
  • Disc diffusion may underestimate mupirocin resistance, particularly low-level resistance, highlighting the need for MIC testing.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
99
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
33
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
62